<DOC>
	<DOCNO>NCT00343642</DOCNO>
	<brief_summary>Our objective determine whether specific dietary intervention fructooligosaccharide ( FOS ) supplement anti-oxidant prebiotic effect whether beneficial treatment Crohn 's Disease ( CD .</brief_summary>
	<brief_title>Dietary Treatment Crohn 's Disease</brief_title>
	<detailed_description>Several epidemiological study therapeutic observation complementary alternative medicine ( CAM ) literature suggest diet key development CD treatment . The investigator take advantage CAM recommendation design dietary intervention . Our preliminary open label study IBD patient show intervention acceptable well-tolerated result improvement , reduce symptom and/or degree inflammation . The investigator seek validate find determine mechanism underlie effect dietary manipulation-such potential effect colonic bacterial microflora . In another pilot study use 16 rDNA bacterial fingerprinting , investigator demonstrate intestinal microflora patient CD differ significantly healthy individual . Whether investigator normalize/change microflora CD patient dietary therapy , however , remain determined . Accordingly , investigator design double blind placebo control study test hypothesis : ( 1 ) dietary manipulation either diet FOS supplement effective CAM therapy prevents CD relapse ( lead maintenance remission ) ( 2 ) dietary manipulation normalize microflora CD patient decrease mucosal oxidative damage . 90 participant expect undergo trial 2:1 chance receive active therapy . The trial seek enroll participant inactive CD medically induce remission within 9 month enrollment . Participants must Crohn 's medication stable dose 3 month , include steroid ( e.g . Prednisone , Entocort ) antibiotic time enrollment . Participants follow till relapse occur 52 week . Participants ask fill variety questionnaire , keep food adverse event diary , research , limit , unprepped flexible sigmoidoscopy colonic tissue collection begin end study period . Significance . This study could provide information suggest diet dietary supplement safe therapy IBD lay groundwork definitive , randomize , control trial .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>1 . Documented ileocolonic colonic CD base classical history classical endoscopic surgical finding histology compatible CD ; 2 . Induction remission medical therapy within 9 month study ; 3 . Inactive CD least 2 week CDAI score less 150 ; 4 . No change IBD medication dose 3 month ; 5 . No change smoke habit month prior enrollment ( smoking may exacerbate CD ) acceptance notchanging smoke habit term study ) . 1 . Patients history bowel obstruction and/or know stricture ( high fiber content may precipitate obstruction ) ; 2 . Patients extensive colonic ileocolonic resection ; 3 . Patients ileostomies colostomy divert fecal stream ; 4 . Patients isolated perianal/anorectal disease ; 5 . Patients surgically induced remission ; 6 . Concomitant infection ( e.g. , C. difficile colitis ) ; 7 . Use antibiotic within 4 week , steroid , herbal remedy diet therapy within 2 week onset trial study ; 8 . Use potential IBD exacerbators NSAIDs within 1 wk study ; 9 . Acute illness require immediate hospitalization CD reason ; 10 . Presence symptomatic organic GI disease CD , hemorrhoid , hiatal hernia ; GERD ; 11 . Preexistent organ failure severe comorbidities may change Gl flora : Liver disease ( cirrhosis persistently abnormal AST ALT 2X &gt; normal ) ; Kidney disease ( creatinine &gt; 2.0 mg/dL ) ; Uncontrolled psychiatric illness ; Clinically important lung disease heart failure ; HIV disease ; Alcoholism ; Transplant recipient ; Patients receive immunosuppressant medication comorbidities ( e.g . Enbrel rheumatoid arthritis ) ; 12 . Presence short bowel syndrome severe malnutrition ideal body weight less equal 90 % predict ; 13 . Estimated survival &lt; 1 year Karnofsky performance status &lt; 50 % ; 14 . Desire become pregnant study current pregnancy nursing ; 15 . Desire change smokingstatus study ; 16 . Daily use anticoagulation antiplatelet medication ; 17 . Complicated IBD anticipation imminent surgical intervention term study ; 18 . Inability regular followup comply study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Crohn 's disease</keyword>
	<keyword>Fructooligosaccharide</keyword>
	<keyword>Inulin</keyword>
	<keyword>Diet</keyword>
	<keyword>Treatment</keyword>
	<keyword>Bacterial flora</keyword>
	<keyword>Oxidative stress</keyword>
</DOC>